9 March 2026 - US biopharmaceutical company Halozyme Therapeutics Inc (NASDAQ:HALO) announced on Friday that Johnson & Johnson (J&J) (NYSE:JNJ) has received approval from the US Food and Drug Administration (FDA) for TECVAYLI (teclistamab-cqy...
9 March 2026 - French pharmaceutical company Servier and US biopharmaceutical company Day One Biopharmaceuticals Inc (Nasdaq:DAWN) on Friday announced a definitive agreement for Servier to acquire Day One for USD21.50 per share in cash, representing ...
9 March 2026 - PureHealth Research LLC, a US-based health and wellness company developing premium, science-backed dietary supplements, announced on Saturday that it has launched a new collection of natural GLP-1 supplements designed to support the bo...